| LSB | LakeShore Biopharma Co Ltd | 0.03 | -96.21% |
| NTBL | Notable Labs Inc Ord | 0.03 | -95.03% |
| TNFA | TNF Pharmaceuticals Inc | 0.05 | -93.11% |
| QLGN | Qualigen Therapeutics, Inc. Common Stock | 0.05 | -92.14% |
| AFMD | Affimed N.V. | 0.06 | -90.89% |
| EPIX | Essa Pharma Inc | 0.08 | -88.11% |
| ENLV | Enlivex Therapeutics Ltd | 0.08 | -87.87% |
| ONCO | Onconetix Inc | 0.09 | -86.70% |
| PBM | Psyence Biomedical Ltd | 0.12 | -83.32% |
| OSRH | Bellevue Life Sciences Acquisition Corp | 0.14 | -79.55% |
| PPBT | Purple Biotech Ltd | 0.14 | -79.13% |
| BDRX | Biodexa Pharmaceuticals Plc | 0.15 | -78.53% |
| ENTO | Entero Therapeutics, Inc. Common Stock | 0.15 | -77.82% |
| ONCT | Oncternal Therapeutics Inc | 0.17 | -75.29% |
| PPCB | Propanc Biopharma Inc | 0.18 | -73.17% |
| PMCB | PharmaCyte Biotech Inc | 0.20 | -71.72% |
| APRE | Aprea Therapeutics Inc | 0.22 | -68.09% |
| GLMD | Galmed Pharmaceuticals Ltd | 0.25 | -64.03% |
| CTXR | Citius Pharmaceuticals Inc | 0.25 | -64.03% |
| NCNA | NuCana plc | 0.28 | -60.11% |
| NXTC | Nextcure Inc | 0.29 | -57.21% |
| REVB | Revelation Biosciences Inc | 0.31 | -55.47% |
| APM | Aptorum Group Ltd - Class A | 0.31 | -54.60% |
| AZTR | Azitra Inc | 0.33 | -52.57% |
| MGX | Metagenomi Inc | 0.34 | -51.12% |
| KTTA | Pasithea Therapeutics Corp | 0.36 | -48.37% |
| BOLD | Boundless Bio Inc | 0.36 | -47.93% |
| SEER | Seer Inc - Class A | 0.39 | -44.16% |
| GRI | GRI Bio Inc | 0.39 | -44.16% |
| ENGN | enGene Holdings Inc | 0.40 | -42.42% |
| ELAB | PMGC Holdings Inc | 0.40 | -41.94% |
| GNPX | Genprex Inc | 0.41 | -39.95% |
| VTGN | VistaGen Therapeutics Inc | 0.42 | -39.52% |
| TCRX | Tscan Therapeutics Inc | 0.42 | -39.42% |
| CMND | Clearmind Medicine Inc | 0.42 | -38.94% |
| VRAX | Virax Biolabs Group Ltd - Class A | 0.42 | -38.79% |
| BRNS | Barinthus Biotherapeutics Plc. | 0.43 | -38.07% |
| BOLT | Bolt Biotherapeutics Inc | 0.43 | -37.78% |
| PLRX | Pliant Therapeutics Inc | 0.43 | -37.49% |
| OGEN | Oragenics Inc | 0.44 | -36.47% |
| LITS | Lite Strategy Inc | 0.44 | -35.60% |
| BBLG | Bone Biologics Corp | 0.47 | -31.40% |
| LNAI | Lunai Bioworks Inc | 0.48 | -30.24% |
| ACET | Adicet Bio Inc | 0.49 | -29.22% |
| TIL | Instil Bio Inc | 0.49 | -29.08% |
| GLPG | Galapagos NV | 0.49 | -28.35% |
| IMA | Ikena Oncology Inc | 0.50 | -26.90% |
| BCYC | Bicycle Therapeutics Plc | 0.51 | -26.46% |
| APVO | Aptevo Therapeutics Inc | 0.51 | -25.88% |
| XBIT | XBiotech Inc | 0.54 | -22.40% |
| SLRN | Acelyrin Inc | 0.56 | -18.60% |
| SCNI | Scinai Immunotherapeutics Ltd | 0.56 | -18.34% |
| GRCE | Acasti Pharma Inc | 0.56 | -18.34% |
| CDT | CDT Equity Inc | 0.57 | -17.73% |
| INAB | IN8bio Inc | 0.59 | -14.57% |
| FBIO | Fortress Biotech Inc | 0.60 | -13.27% |
| ACHL | Achilles Therapeutics Plc | 0.61 | -11.38% |
| NKTX | Nkarta Inc | 0.62 | -10.66% |
| DWTX | Virios Therapeutics Inc | 0.63 | -8.91% |
| ORMP | Oramed Pharmaceuticals Inc | 0.64 | -7.90% |
| MURA | Mural Oncology plc | 0.64 | -7.03% |
| PMVP | PMV Pharmaceuticals Inc | 0.65 | -6.30% |
| HYPD | Eyenovia Inc | 0.65 | -5.29% |
| MBIO | Mustang Bio Inc | 0.65 | -5.14% |
| VOR | Vor Biopharma Inc | 0.66 | -5.00% |
| CDIO | Cardio Diagnostics Holdings Inc | 0.66 | -5.00% |
| CLDI | Calidi Biotherapeutics Inc | 0.66 | -3.98% |
| ACRV | Acrivon Therapeutics Inc | 0.67 | -2.53% |
| KROS | Keros Therapeutics Inc | 0.69 | -0.36% |
| AGIO | Agios Pharmaceuticals Inc | 0.69 | -0.21% |
| HLVX | HilleVax Inc | 0.71 | +2.78% |
| PEPG | PepGen Inc | 0.71 | +3.27% |
| TOVX | Theriva Biologics Inc | 0.72 | +4.43% |
| XLO | Xilio Therapeutics Inc | 0.72 | +5.01% |
| BGMS | Bio Green Med Solution Inc | 0.73 | +5.44% |
| LPCN | Lipocine Inc | 0.74 | +7.18% |
| DRMA | Dermata Therapeutics Inc | 0.75 | +8.20% |
| VIVS | VivoSim Labs Inc | 0.76 | +10.09% |
| ARTL | Artelo Biosciences Inc | 0.76 | +10.67% |
| PHIO | Phio Pharmaceuticals Corp | 0.77 | +11.10% |
| IMMP | Immutep Ltd | 0.78 | +13.28% |
| ATYR | Atyr Pharma Inc | 0.79 | +15.16% |
| TNXP | Tonix Pharmaceuticals Holding Corp | 0.80 | +16.61% |
| BIVI | BioVie Inc - Class A | 0.81 | +17.05% |
| NEUP | Neuphoria Therapeutics Inc | 0.81 | +17.77% |
| KPRX | Kiora Pharmaceuticals Inc | 0.84 | +21.40% |
| LENZ | LENZ Therapeutics Inc | 0.84 | +21.54% |
| BLRX | Bioline Rx Ltd | 0.84 | +21.54% |
| MBRX | Moleculin Biotech Inc | 0.85 | +23.43% |
| JANX | Janux Therapeutics Inc | 0.85 | +23.43% |
| ENSC | Ensysce Biosciences Inc | 0.85 | +24.01% |
| TRDA | Entrada Therapeutics Inc | 0.86 | +24.30% |
| RNA | Atrium Therapeutics Inc | 0.86 | +24.59% |
| ENVB | Enveric Biosciences Inc | 0.86 | +25.17% |
| THRD | Third Harmonic Bio Inc | 0.89 | +29.23% |
| VYNE | VYNE Therapeutics Inc | 0.89 | +29.38% |
| SAVA | Cassava Sciences Inc. | 0.92 | +33.73% |
| ADVM | Adverum Biotechnologies Inc | 0.93 | +34.89% |
| NBP | NovaBridge Biosciences. | 0.94 | +36.48% |
| ACXP | Acurx Pharmaceuticals Inc | 0.96 | +39.53% |
| AARD | Aardvark Therapeutics Inc | 0.98 | +41.85% |
| PRTC | PureTech Health plc American Depositary Shares | 1.00 | +45.77% |
| ALGS | Aligos Therapeutics Inc | 1.01 | +46.06% |
| FDMT | 4D Molecular Therapeutics Inc | 1.01 | +46.35% |
| INTS | Intensity Therapeutics Inc | 1.01 | +46.93% |
| XBIO | Xenetic Biosciences Inc | 1.02 | +47.80% |
| CVAC | CureVac N.V. | 1.03 | +49.10% |
| BNTX | BioNTech SE | 1.03 | +49.97% |
| BDTX | Black Diamond Therapeutics Inc | 1.04 | +51.42% |
| BCTX | BriaCell Therapeutics Corp - New | 1.04 | +51.57% |
| OKUR | Reneo Pharmaceuticals Inc - Class A | 1.05 | +52.29% |
| IMUX | Immunic Inc | 1.05 | +53.02% |
| IMRN | Immuron Ltd | 1.05 | +53.02% |
| ARCT | Arcturus Therapeutics Holdings Inc | 1.06 | +54.18% |
| ERNA | Ernexa Therapeutics Inc | 1.08 | +56.35% |
| CURX | Curanex Pharmaceuticals Inc | 1.09 | +58.38% |
| CLGN | CollPlant Biotechnologies Ltd New | 1.09 | +58.38% |
| PLRZ | Polyrizon Ltd | 1.11 | +60.99% |
| SRPT | Sarepta Therapeutics Inc | 1.11 | +61.72% |
| SABS | SAB Biotherapeutics Inc | 1.11 | +61.72% |
| CANF | Can-Fite Biopharma Ltd | 1.11 | +61.72% |
| UPB | Upstream Bio Inc | 1.12 | +62.59% |
| MTVA | MetaVia Inc | 1.12 | +62.59% |
| LYEL | Lyell Immunopharma Inc | 1.13 | +63.32% |
| CRBP | Corbus Pharmaceuticals Holdings Inc | 1.13 | +63.75% |
| RADX | Radiopharm Theranostics Ltd | 1.13 | +63.90% |
| AKTX | Akari Therapeutics Plc | 1.14 | +65.52% |
| QNRX | Quoin Pharmaceuticals Ltd | 1.16 | +67.96% |
| ARVN | Arvinas Inc | 1.17 | +68.97% |
| IBIO | iBio Inc | 1.17 | +69.55% |
| DNA | Ginkgo Bioworks Holdings Inc - Class A | 1.17 | +69.70% |
| CMMB | Chemomab Therapeutics Ltd | 1.18 | +70.86% |
| SPRC | SciSparc Ltd | 1.19 | +72.05% |
| VYGR | Voyager Therapeutics Inc | 1.19 | +73.03% |
| RCKT | Rocket Pharmaceuticals Inc | 1.19 | +73.03% |
| FATE | Fate Therapeutics Inc | 1.21 | +75.93% |
| SILO | SILO Pharma Inc | 1.22 | +77.38% |
| TARA | Protara Therapeutics Inc | 1.23 | +78.40% |
| JAGX | Jaguar Health Inc | 1.23 | +78.46% |
| ADIL | Adial Pharmaceuticals Inc | 1.23 | +78.98% |
| INVA | Innoviva Inc | 1.24 | +79.85% |
| ATOS | Atossa Therapeutics Inc | 1.25 | +80.72% |
| SNSE | Sensei Biotherapeutics Inc | 1.26 | +82.90% |
| IMRX | Immuneering Corp Class A | 1.26 | +82.90% |
| CVM | Cel-Sci Corp | 1.29 | +87.25% |
| ALXO | Alx Oncology Holdings Inc | 1.30 | +88.26% |
| CELZ | Creative Medical Technology Holdings Inc | 1.30 | +88.70% |
| IVVD | Invivyd Inc | 1.31 | +89.57% |
| VNDA | Vanda Pharmaceuticals Inc | 1.31 | +89.71% |
| IKT | Inhibikase Therapeutics Inc | 1.31 | +90.29% |
| KRRO | Korro Bio Inc | 1.31 | +90.44% |
| OABI | OmniAb Inc | 1.31 | +90.58% |
| ADXN | Addex Therapeutics Ltd | 1.32 | +91.16% |
| QNCX | Quince Therapeutics Inc | 1.33 | +92.76% |
| LXEO | Lexeo Therapeutics Inc | 1.40 | +103.20% |
| ZNTL | Zentalis Pharmaceuticals Inc | 1.40 | +103.49% |
| PASG | Passage Bio Inc | 1.41 | +104.36% |
| PRTA | Prothena Corporation plc | 1.42 | +105.52% |
| RIGL | Rigel Pharmaceuticals | 1.42 | +105.81% |
| TNYA | Tenaya Therapeutics Inc | 1.43 | +106.97% |
| MREO | Mereo Biopharma Group Plc | 1.43 | +107.12% |
| VERU | Veru Inc | 1.43 | +107.41% |
| KLRS | Kalaris Therapeutics Inc | 1.44 | +109.44% |
| CRIS | Curis Inc | 1.45 | +110.60% |
| ICU | SeaStar Medical Holding Corp | 1.45 | +110.89% |
| HOWL | Werewolf Therapeutics Inc | 1.45 | +110.89% |
| AVIR | Atea Pharmaceuticals Inc | 1.50 | +117.85% |
| HCWB | HCW Biologics Inc | 1.50 | +118.14% |
| IPSC | Century Therapeutics Inc | 1.51 | +118.43% |
| CLRB | Cellectar Biosciences Inc | 1.51 | +119.74% |
| LGVN | Longeveron Inc - Class A | 1.52 | +120.17% |
| PMN | ProMIS Neurosciences Inc | 1.52 | +120.46% |
| BBOT | BridgeBio Oncology Therapeutics Inc Com | 1.53 | +121.91% |
| GNTA | Genenta Science SpA | 1.55 | +124.38% |
| CRMD | CorMedix Inc | 1.55 | +124.96% |
| SGMT | Sagimet Biosciences Inc - Class A | 1.55 | +125.54% |
| RXRX | Recursion Pharmaceuticals Inc - Class A | 1.57 | +127.57% |
| ZURA | Zura Bio Ltd - Class A | 1.61 | +134.10% |
| MOLN | Molecular Partners AG | 1.62 | +135.55% |
| MNOV | Medicinova Inc | 1.64 | +137.29% |
| INMB | INmune Bio Inc | 1.65 | +138.74% |
| MRVI | Maravai LifeSciences Holdings Inc - Class A | 1.65 | +138.98% |
| XTLB | X.T.L. Biopharmaceuticals Ltd | 1.65 | +139.84% |
| ABCL | AbCellera Biologics Inc | 1.66 | +140.62% |
| MTNB | Matinas Biopharma Holdings Inc | 1.69 | +144.97% |
| CTNM | Contineum Therapeutics Inc - Class A | 1.69 | +145.12% |
| CCCC | C4 Therapeutics Inc | 1.69 | +145.12% |
| XNCR | Xencor Inc | 1.71 | +147.58% |
| WHWK | Whitehawk Therapeutics Inc | 1.71 | +148.16% |
| IMAB | I-Mab | 1.73 | +150.40% |
| ANTX | AN2 Therapeutics Inc | 1.73 | +150.48% |
| CRBU | Caribou Biosciences Inc | 1.73 | +150.92% |
| KAPA | Kairos Pharma Ltd | 1.73 | +151.36% |
| MRKR | Marker Therapeutics Inc | 1.74 | +152.37% |
| SLDB | Solid Biosciences Inc | 1.74 | +152.52% |
| TVRD | Cara Therapeutics Inc | 1.75 | +153.24% |
| TTNP | Titan Pharmaceuticals Inc (de) | 1.76 | +155.42% |
| VIR | Vir Biotechnology Inc | 1.76 | +156.00% |
| OLMA | Olema Pharmaceuticals Inc | 1.78 | +158.90% |
| AVXL | Anavex Life Sciences Corporation | 1.80 | +161.07% |
| BMRN | Biomarin Pharmaceutical Inc | 1.80 | +161.36% |
| SVA | Sinovac Biotech Ltd | 1.82 | +163.39% |
| RLYB | Rallybio Corp | 1.84 | +166.58% |
| CMPX | Compass Therapeutics Inc | 1.85 | +168.91% |
| ABOS | Acumen Pharmaceuticals Inc | 1.85 | +168.91% |
| NGNE | Neoleukin Therapeutics Inc | 1.86 | +169.92% |
| ORIC | ORIC Pharmaceuticals Inc | 1.87 | +171.66% |
| FBLG | FibroBiologics Inc | 1.88 | +173.11% |
| ASBP | Aspire Biopharma Holdings Inc | 1.90 | +175.58% |
| PULM | Pulmatrix Inc | 1.91 | +176.74% |
| ALT | Altimmune Inc | 1.93 | +179.78% |
| ATHE | Alterity Therapeutics Ltd | 1.97 | +185.44% |
| NAUT | Nautilus Biotechnology Inc | 1.99 | +188.49% |
| CGEN | Compugen Ltd | 2.00 | +189.94% |
| ALZN | Alzamend Neuro Inc | 2.00 | +190.52% |
| CYCN | Cyclerion Therapeutics Inc | 2.01 | +191.39% |
| GTBP | GT Biopharma Inc | 2.02 | +192.40% |
| CTMX | CytomX Therapeutics Inc | 2.03 | +194.14% |
| BNTC | Benitec Biopharma Inc | 2.03 | +194.58% |
| GPCR | Structure Therapeutics Inc | 2.04 | +195.88% |
| REGN | Regeneron Pharmaceuticals Inc | 2.06 | +198.20% |
| SER | AgeX Therapeutics Inc | 2.06 | +198.35% |
| GRDX | Entero Therapeutics Inc | 2.09 | +202.55% |
| XFOR | X4 Pharmaceuticals Inc | 2.09 | +202.84% |
| SNGX | Soligenix Inc | 2.10 | +203.86% |
| IVA | Inventiva | 2.10 | +205.02% |
| ARMP | Armata Pharmaceuticals Inc | 2.11 | +206.04% |
| STRO | Sutro Biopharma Inc | 2.11 | +206.18% |
| COYA | Coya Therapeutics Inc | 2.12 | +207.05% |
| EVAX | Evaxion Biotech A/S | 2.14 | +210.24% |
| DTIL | Precision Biosciences Inc | 2.14 | +210.39% |
| LBRX | LB Pharmaceuticals Inc | 2.15 | +211.84% |
| TRAW | Traws Pharma Inc | 2.16 | +213.72% |
| WVE | Wave Life Sciences Ltd | 2.17 | +214.88% |
| ABEO | Abeona Therapeutics Inc | 2.17 | +215.17% |
| PCSA | Processa Pharmaceuticals Inc | 2.19 | +217.06% |
| PCVX | Vaxcyte Inc | 2.19 | +217.35% |
| CGEM | Cullinan Oncology Inc | 2.21 | +220.83% |
| HRMY | Harmony Biosciences Holdings Inc | 2.26 | +227.21% |
| HIND | ReShape Lifesciences Inc | 2.26 | +228.37% |
| ASMB | Assembly Biosciences Inc | 2.26 | +228.37% |
| LRMR | Larimar Therapeutics Inc | 2.27 | +228.95% |
| MDXG | Mimedx Group Inc | 2.27 | +229.53% |
| OVID | Ovid Therapeutics Inc | 2.27 | +229.68% |
| PALI | Palisade Bio Inc | 2.29 | +232.43% |
| TECX | AvroBio Inc | 2.30 | +233.16% |
| IMTX | Immatics N.V | 2.31 | +234.61% |
| MCRB | Seres Therapeutics Inc | 2.32 | +236.35% |
| NCEL | NLS Pharmaceutics Ltd | 2.35 | +241.57% |
| PLX | Protalix BioTherapeutics Inc | 2.37 | +244.18% |
| KYTX | Kyverna Therapeutics Inc | 2.38 | +245.34% |
| PTN | Palatin Technologies Inc | 2.38 | +245.92% |
| ACOG | Alpha Cognition Inc | 2.39 | +246.79% |
| IOVA | Iovance Biotherapeutics Inc | 2.39 | +247.23% |
| EVMN | Evommune Inc | 2.42 | +251.43% |
| ALDX | Aldeyra Therapeutics Inc | 2.45 | +254.91% |
| TENX | Tenax Therapeutics Inc | 2.49 | +260.57% |
| LEXX | Lexaria Bioscience Corp | 2.50 | +262.17% |
| SRZN | Surrozen Inc | 2.50 | +263.33% |
| IMNN | Imunon Inc | 2.53 | +266.52% |
| CNTX | Context Therapeutics Inc | 2.53 | +267.53% |
| ARTV | Artiva Biotherapeutics Inc | 2.54 | +268.11% |
| MRNA | Moderna Inc | 2.54 | +268.55% |
| CRVO | CervoMed Inc | 2.55 | +270.00% |
| BCAX | Bicara Therapeutics Inc | 2.58 | +274.35% |
| CBUS | Cibus Global Ltd. Class A | 2.58 | +274.49% |
| BEAM | Beam Therapeutics Inc | 2.60 | +277.83% |
| OCS | Oculis Holding AG | 2.62 | +280.01% |
| NRSN | NeuroSense Therapeutics Ltd | 2.64 | +283.34% |
| GMAB | Genmab | 2.64 | +283.49% |
| GDTC | CytoMed Therapeutics Ltd | 2.65 | +284.94% |
| GOSS | Gossamer Bio Inc | 2.66 | +286.39% |
| GLUE | Monte Rosa Therapeutics Inc | 2.67 | +287.98% |
| NERV | Minerva Neurosciences Inc | 2.68 | +288.42% |
| BCAB | BioAtla Inc | 2.68 | +288.85% |
| CBIO | N/A | 2.68 | +289.14% |
| ALLO | Allogene Therapeutics Inc | 2.69 | +289.58% |
| PTHS | Channel Therapeutics Corporation | 2.71 | +293.78% |
| DRUG | Bright Minds Biosciences Inc | 2.73 | +295.24% |
| PBYI | Puma Biotechnology Inc | 2.78 | +303.65% |
| IDYA | Ideaya Biosciences Inc | 2.79 | +304.08% |
| CHRS | Coherus Biosciences Inc | 2.79 | +304.08% |
| CRSP | CRISPR Therapeutics AG | 2.79 | +305.24% |
| SPRO | Spero Therapeutics Inc | 2.81 | +307.71% |
| CRNX | Crinetics Pharmaceuticals Inc | 2.82 | +309.59% |
| ZLAB | Zai Lab Ltd | 2.83 | +309.88% |
| ENTA | Enanta Pharmaceuticals Inc | 2.83 | +310.75% |
| EQ | Equillium Inc | 2.84 | +311.62% |
| ANRO | Alto Neuroscience Inc | 2.84 | +311.62% |
| MAIA | MAIA Biotechnology Inc | 2.85 | +312.93% |
| LSTA | Lisata Therapeutics Inc | 2.88 | +316.99% |
| NTLA | Intellia Therapeutics Inc | 2.90 | +320.33% |
| NRXP | NRX Pharmaceuticals Inc | 2.90 | +321.20% |
| TBPH | Theravance Biopharma Inc | 2.92 | +324.10% |
| CRDF | Cardiff Oncology Inc | 2.94 | +325.69% |
| CYBN | Cybin Inc | 2.94 | +325.84% |
| FTRE | Fortrea Holdings Inc | 2.94 | +326.27% |
| ICCC | Immucell Corp | 2.98 | +332.80% |
| MNPR | Monopar Therapeutics Inc | 2.99 | +333.09% |
| ACAD | Acadia Pharmaceuticals Inc | 2.99 | +334.25% |
| MLEC | Moolec Science SA | 3.00 | +334.45% |
| RLMD | Relmada Therapeutics Inc | 3.01 | +336.14% |
| SKYE | Skye Bioscience Inc | 3.04 | +341.21% |
| XRTX | XORTX Therapeutics Inc | 3.05 | +341.79% |
| DSGN | Design Therapeutics Inc | 3.05 | +342.81% |
| AURA | Aura Biosciences Inc | 3.06 | +344.11% |
| CNTB | Connect Biopharma Holdings Ltd | 3.07 | +345.71% |
| RANI | Rani Therapeutics Holdings Inc Class A | 3.10 | +349.34% |
| PSTV | Plus Therapeutics Inc | 3.10 | +349.92% |
| GERN | Geron Corp | 3.12 | +352.82% |
| JBIO | Jade Biosciences Inc | 3.13 | +354.41% |
| RZLT | Rezolute Inc | 3.14 | +355.43% |
| MPLT | MapLight Therapeutics Inc | 3.15 | +357.31% |
| JAZZ | Jazz Pharmaceuticals plc | 3.18 | +360.94% |
| OCUL | Ocular Therapeutix Inc | 3.19 | +361.95% |
| ABUS | Arbutus Biopharma Corp | 3.23 | +368.05% |
| ABVC | ABVC BioPharma Inc | 3.23 | +369.06% |
| PHAR | Pharming Group N.V. | 3.27 | +374.72% |
| MLYS | Mineralys Therapeutics Inc | 3.28 | +375.73% |
| NRIX | Nurix Therapeutics Inc | 3.29 | +377.47% |
| REPL | Replimune Group Inc | 3.32 | +381.24% |
| BRTX | BioRestorative Therapies Inc | 3.32 | +381.68% |
| NAGE | Niagen Bioscience Inc | 3.35 | +385.45% |
| ZBIO | Zenas Biopharma Inc | 3.36 | +387.48% |
| NKTR | Nektar Therapeutics | 3.36 | +387.77% |
| MBX | MBX Biosciences Inc | 3.37 | +388.93% |
| PYXS | Pyxis Oncology Inc | 3.39 | +392.27% |
| RNXT | RenovoRx Inc | 3.40 | +393.86% |
| STTK | Shattuck Labs Inc | 3.42 | +395.60% |
| ADCT | Adc Therapeutics SA | 3.42 | +396.62% |
| COCP | Cocrystal Pharma Inc | 3.43 | +397.92% |
| ALLR | Allarity Therapeutics Inc | 3.45 | +400.24% |
| VRDN | Viridian Therapeutics Inc | 3.46 | +401.26% |
| CGTX | Cognition Therapeutics Inc | 3.46 | +401.26% |
| IMNM | Immunome Inc | 3.49 | +406.19% |
| CING | Cingulate Inc | 3.49 | +406.34% |
| NNVC | NanoViricides Inc | 3.52 | +409.82% |
| DYN | Dyne Therapeutics Inc | 3.52 | +409.96% |
| DNLI | Denali Therapeutics Inc | 3.53 | +412.28% |
| RAPP | Rapport Therapeutics Inc | 3.57 | +417.94% |
| AUPH | Aurinia Pharmaceuticals Inc | 3.58 | +418.52% |
| EPRX | Eupraxia Pharmaceuticals Inc | 3.58 | +419.10% |
| RPRX | Royalty Pharma plc - Class A | 3.58 | +419.10% |
| PRQR | ProQR Therapeutics N.V | 3.59 | +420.26% |
| IMCR | Immunocore Holdings plc | 3.61 | +423.02% |
| SEPN | Septerna Inc | 3.62 | +425.34% |
| AUTL | Autolus Therapeutics plc | 3.64 | +428.53% |
| MESO | Mesoblast Ltd | 3.65 | +429.40% |
| INCY | Incyte Corp | 3.67 | +432.01% |
| IRON | Disc Medicine Inc | 3.73 | +441.29% |
| GNFT | GENFIT S.A. American Depositary Shares | 3.77 | +446.48% |
| AVTX | Avalo Therapeutics Inc | 3.78 | +448.40% |
| ANNX | Annexon Inc | 3.78 | +448.40% |
| CPRX | Catalyst Pharmaceuticals Inc | 3.79 | +449.41% |
| TCRT | Alaunos Therapeutics Inc | 3.79 | +449.99% |
| XENE | Xenon Pharmaceuticals Inc | 3.81 | +453.18% |
| MAZE | Maze Therapeutics Inc | 3.83 | +455.36% |
| DNTH | Dianthus Therapeutics Inc | 3.85 | +458.70% |
| SPRB | Spruce Biosciences Inc | 3.85 | +459.13% |
| ZVRA | Zevra Therapeutics Inc | 3.88 | +462.61% |
| JSPR | Jasper Therapeutics Inc | 3.89 | +463.77% |
| TYRA | Tyra Biosciences Inc | 3.90 | +465.80% |
| VSTM | Verastem Inc | 3.93 | +470.44% |
| KALA | Kala Bio Inc | 4.06 | +488.86% |
| TECH | Bio-Techne Corp | 4.09 | +492.93% |
| CRVS | Corvus Pharmaceuticals Inc | 4.10 | +494.38% |
| LXRX | Lexicon Pharmaceuticals Inc | 4.12 | +497.13% |
| ESLA | Estrella Immunopharma Inc | 4.13 | +499.45% |
| KYMR | Kymera Therapeutics Inc | 4.18 | +505.98% |
| CLYM | Eliem Therapeutics Inc | 4.18 | +506.27% |
| RNAZ | TransCode Therapeutics Inc | 4.18 | +506.99% |
| ACRS | Aclaris Therapeutics Inc | 4.21 | +510.62% |
| MIST | Milestone Pharmaceuticals Inc | 4.21 | +511.06% |
| KZIA | Kazia Therapeutics Ltd | 4.25 | +516.70% |
| EYPT | EyePoint Pharmaceuticals Inc | 4.28 | +521.06% |
| NMRA | Neumora Therapeutics Inc | 4.30 | +523.53% |
| IFRX | InflaRx N.V. | 4.30 | +524.25% |
| VTVT | vTv Therapeutics Inc - Class A | 4.32 | +527.21% |
| AVBP | ArriVent BioPharma Inc | 4.39 | +536.73% |
| GRCL | Gracell Biotechnologies Inc | 4.39 | +536.87% |
| CADL | Candel Therapeutics Inc | 4.43 | +542.09% |
| MDWD | MediWound Ltd | 4.44 | +543.54% |
| CGON | Cg Oncology Inc | 4.44 | +543.54% |
| YMAB | Y-Mabs Therapeutics Inc | 4.46 | +546.84% |
| STOK | Stoke Therapeutics Inc | 4.48 | +550.36% |
| ETNB | 89bio Inc | 4.49 | +551.33% |
| BMEA | Biomea Fusion Inc | 4.50 | +552.68% |
| VERA | Vera Therapeutics Inc - Class A | 4.54 | +558.77% |
| DBVT | DBV Technologies | 4.57 | +562.83% |
| RLAY | Relay Therapeutics Inc | 4.58 | +564.00% |
| ROIV | Roivant Sciences Ltd | 4.61 | +569.22% |
| XOMA | XOMA Corp | 4.67 | +577.19% |
| IGC | IGC Pharma Inc | 4.68 | +578.35% |
| QTTB | Q32 Bio Inc | 4.71 | +583.43% |
| PRAX | Praxis Precision Medicines Inc | 4.76 | +590.10% |
| SLGL | Sol-Gel Technologies Ltd | 4.76 | +590.39% |
| TRML | Tourmaline Bio Inc | 4.77 | +591.49% |
| LGND | Ligand Pharmaceuticals Inc - Class B | 4.89 | +609.10% |
| CLDX | Celldex Therapeutics Inc | 4.92 | +614.18% |
| APGE | Apogee Therapeutics Inc | 4.96 | +619.26% |
| ELVN | Enliven Therapeutics Inc | 4.97 | +621.00% |
| NUVB | Nuvation Bio Inc - Class A | 4.99 | +623.75% |
| GANX | Gain Therapeutics Inc | 4.99 | +624.33% |
| AIM | AIM ImmunoTech Inc. | 5.01 | +626.65% |
| CLLS | Cellectis | 5.02 | +628.10% |
| ADMA | Adma Biologics Inc | 5.04 | +631.00% |
| CABA | Cabaletta Bio Inc | 5.09 | +638.26% |
| VANI | Vivani Medical Inc | 5.11 | +641.16% |
| NAMS | NewAmsterdam Pharma Company NV | 5.15 | +646.96% |
| MLTX | MoonLake Immunotherapeutics - Class A | 5.16 | +648.41% |
| CDXS | Codexis Inc | 5.19 | +652.76% |
| PRLD | Prelude Therapeutics Inc | 5.23 | +658.56% |
| ANIX | Anixa Biosciences Inc | 5.23 | +658.56% |
| GHRS | GH Research PLC | 5.30 | +668.71% |
| VCEL | Vericel Corp | 5.31 | +670.16% |
| RCUS | Arcus Biosciences Inc | 5.31 | +670.16% |
| SION | Sionna Therapeutics Inc | 5.33 | +673.07% |
| BYSI | BeyondSpring Inc | 5.38 | +680.32% |
| ENTX | Entera Bio Ltd | 5.40 | +683.22% |
| CAPR | Capricor Therapeutics Inc | 5.40 | +683.22% |
| IBO | Impact BioMedical Inc | 5.42 | +686.12% |
| CUE | Cue Biopharma Inc | 5.42 | +686.12% |
| GUTS | Fractyl Health Inc | 5.43 | +687.57% |
| ALMS | Alumis Inc | 5.43 | +687.57% |
| FBRX | Forte Biosciences Inc | 5.44 | +689.02% |
| UNCY | Unicycive Therapeutics Inc | 5.59 | +710.78% |
| GNLX | Genelux Corp | 5.60 | +712.23% |
| HURA | TuHURA Biosciences Inc | 5.61 | +713.68% |
| VALN | Valneva SE | 5.64 | +718.03% |
| LCTX | Lineage Cell Therapeutics Inc | 5.69 | +725.28% |
| KLTO | Klotho Neurosciences Inc Com | 5.71 | +728.18% |
| GYRE | Gyre Therapeutics Inc | 5.71 | +728.18% |
| SVRA | Savara Inc | 5.74 | +732.53% |
| SLN | Silence Therapeutics Plc | 5.75 | +733.98% |
| ACIU | AC Immune SA | 5.78 | +738.33% |
| ABSI | Absci Corp | 5.78 | +738.33% |
| VRTX | Vertex Pharmaceuticals Inc | 5.84 | +747.04% |
| ONC | BeiGene Ltd | 5.84 | +747.04% |
| OBIO | Orchestra BioMed Holdings Inc | 5.84 | +747.04% |
| ELDN | Eledon Pharmaceuticals Inc | 5.97 | +765.89% |
| DMAC | DiaMedica Therapeutics Inc | 6.08 | +781.85% |
| EVGN | Evogene Ltd | 6.18 | +796.35% |
| VRCA | Verrica Pharmaceuticals Inc | 6.20 | +799.25% |
| CMRX | Chimerix Inc | 6.30 | +813.10% |
| PVLA | Palvella Therapeutics Inc | 6.31 | +815.21% |
| NTRB | Nutriband Inc | 6.31 | +815.21% |
| PRME | Prime Medicine Inc | 6.38 | +825.36% |
| SANA | Sana Biotechnology Inc | 6.56 | +851.47% |
| ADAG | Adagene Inc | 6.67 | +867.42% |
| LEGN | Legend Biotech Corp | 6.70 | +871.77% |
| VKTX | Viking Therapeutics Inc | 6.76 | +880.47% |
| EXEL | Exelixis Inc | 6.83 | +890.63% |
| BLTE | Belite Bio Inc | 6.88 | +897.88% |
| IMMX | Immix Biopharma Inc | 6.89 | +899.33% |
| CALC | CalciMedica Inc | 6.98 | +912.38% |
| ATAI | ATAI Life Sciences N.V. | 7.00 | +915.28% |
| HYFT | MindWalk Holdings Corp | 7.02 | +918.18% |
| SLXN | Silexion Therapeutics Corp | 7.07 | +925.44% |
| EWTX | Edgewise Therapeutics Inc | 7.18 | +941.39% |
| CVKD | Cadrenal Therapeutics Inc | 7.23 | +948.64% |
| KURA | Kura Oncology Inc | 7.25 | +951.54% |
| CAMP | CAMP4 Therapeutics Corp | 7.29 | +957.35% |
| TSHA | Taysha Gene Therapies Inc | 7.32 | +961.70% |
| KRYS | Krystal Biotech Inc | 7.34 | +964.60% |
| TELO | Telomir Pharmaceuticals Inc | 7.38 | +970.40% |
| ARGX | Argen X SE | 7.51 | +989.25% |
| TARS | Tarsus Pharmaceuticals Inc | 7.55 | +995.06% |
| IMVT | Immunovant Inc | 7.61 | +1003.76% |
| TLX | Telix Pharmaceuticals Ltd | 7.67 | +1012.46% |
| APLT | Applied Therapeutics Inc | 7.72 | +1019.71% |
| ORKA | ARCA biopharma Inc | 7.98 | +1057.42% |
| ACHV | Achieve Life Sciences Inc | 7.99 | +1058.87% |
| FENC | Fennec Pharmaceuticals Inc | 8.08 | +1071.93% |
| PHVS | Pharvaris NV | 8.09 | +1073.38% |
| APLM | Apollomics Inc - Class A | 8.15 | +1082.08% |
| CAI | Caris Life Sciences Inc - Class A | 8.17 | +1084.98% |
| NUVL | Nuvalent Inc - Class A | 8.30 | +1103.84% |
| XCUR | Exicure Inc | 8.39 | +1116.89% |
| AAPG | Ascentage Pharma Group International | 8.40 | +1118.34% |
| OMER | Omeros Corporation | 8.44 | +1124.14% |
| ARDX | Ardelyx Inc | 9.29 | +1247.43% |
| HRTX | Heron Therapeutics Inc | 9.36 | +1257.58% |
| COGT | Cogent Biosciences Inc | 9.87 | +1331.55% |
| CELU | Celularity Inc - Class A | 9.89 | +1334.45% |
| PYPD | Polypid Ltd | 9.98 | +1347.50% |
| LIXT | Lixte Biotechnology Holdings Inc | 10.01 | +1351.86% |
| PTGX | Protagonist Therapeutics Inc | 10.39 | +1406.97% |
| ZYME | Zymeworks BC Inc | 10.47 | +1418.57% |
| ERAS | Erasca Inc | 10.57 | +1433.08% |
| TNGX | Tango Therapeutics Inc | 10.60 | +1437.43% |
| SNTI | Senti Biosciences Inc | 11.00 | +1495.45% |
| TRVI | Trevi Therapeutics Inc | 11.05 | +1502.70% |
| QURE | uniQure N.V. | 11.17 | +1520.10% |
| INKT | MiNK Therapeutics Inc | 11.33 | +1543.31% |
| TGTX | TG Therapeutics Inc | 11.38 | +1550.56% |
| MGNX | Macrogenics Inc | 11.60 | +1582.47% |
| DRTS | Alpha Tau Medical Ltd | 12.02 | +1643.39% |
| KPTI | Karyopharm Therapeutics Inc | 12.05 | +1647.74% |
| CORT | Corcept Therapeutics Inc | 12.22 | +1672.39% |
| BCDA | BioCardia Inc | 12.35 | +1691.25% |
| ACTU | Actuate Therapeutics Inc | 12.58 | +1724.61% |
| CNTA | Centessa Pharmaceuticals plc | 12.60 | +1727.51% |
| SYRE | Spyre Therapeutics Inc | 12.66 | +1736.21% |
| BHVN | Biohaven Ltd | 12.87 | +1766.67% |
| SLS | SELLAS Life Sciences Group Inc | 13.09 | +1798.58% |
| OSTX | OS Therapies Inc | 13.65 | +1879.80% |
| ATNM | Actinium Pharmaceuticals Inc | 13.75 | +1894.31% |
| OKYO | OKYO Pharma Ltd - New | 14.11 | +1946.52% |
| GOVX | Geovax Labs Inc | 14.14 | +1950.87% |
| LTRN | Lantern Pharma Inc | 14.37 | +1984.23% |
| INO | Inovio Pharmaceuticals Inc | 14.44 | +1994.38% |
| NRXS | Neuraxis Inc | 14.66 | +2026.29% |
| LPTX | Leap Therapeutics Inc | 14.83 | +2050.31% |
| SPRY | ARS Pharmaceuticals Inc | 14.98 | +2072.71% |
| ARQT | Arcutis Biotherapeutics Inc | 15.02 | +2078.51% |
| PDSB | PDS Biotechnology Corporation | 15.20 | +2104.62% |
| RGNX | Regenxbio Inc | 15.50 | +2148.13% |
| ABVX | Abivax | 15.80 | +2191.64% |
| ATRA | Atara Biotherapeutics Inc | 16.14 | +2240.95% |
| ALEC | Alector Inc | 16.31 | +2265.61% |
| ARWR | Arrowhead Pharmaceuticals Inc | 16.77 | +2332.33% |
| KOD | Kodiak Sciences Inc | 17.53 | +2442.56% |
| CSBR | Champions Oncology Inc | 18.32 | +2557.14% |
| SRRK | Scholar Rock Holding Corp | 19.14 | +2676.07% |
| NVCT | Nuvectis Pharma Inc | 19.23 | +2689.13% |
| URGN | UroGen Pharma Ltd | 19.27 | +2694.93% |
| IPHA | Innate Pharma | 20.10 | +2815.31% |
| MDGL | Madrigal Pharmaceuticals Inc | 20.25 | +2837.07% |
| SMMT | Summit Therapeutics Inc | 20.32 | +2847.22% |
| RVMD | Revolution Medicines Inc | 20.43 | +2863.18% |
| DYAI | Dyadic International Inc DE | 21.01 | +2947.30% |
| MTSR | Metsera Inc | 21.96 | +3085.07% |
| TLSA | Tiziana Life Sciences Ltd | 22.09 | +3103.94% |
| ANVS | Annovis Bio Inc | 22.61 | +3179.37% |
| TPST | Tempest Therapeutics Inc | 23.24 | +3270.74% |
| ASND | Ascendis Pharma A/S | 23.43 | +3298.30% |
| MIRM | Mirum Pharmaceuticals Inc | 23.64 | +3328.76% |
| IRD | Ocuphire Pharma Inc | 23.82 | +3354.86% |
| IONS | Ionis Pharmaceuticals Inc | 25.08 | +3537.61% |
| PHAT | Phathom Pharmaceuticals Inc | 25.37 | +3579.68% |
| EDSA | Edesa Biotech Inc | 25.43 | +3588.38% |
| HUMA | Humacyte Inc | 25.79 | +3640.59% |
| TTRX | Turn Therapeutics Inc | 26.93 | +3805.94% |
| RNTX | Rein Therapeutics Inc | 28.17 | +3985.79% |
| INSM | Insmed Inc | 28.97 | +4101.82% |
| RNAC | Cartesian Therapeutics Inc | 31.26 | +4433.97% |
| NVAX | Novavax Inc | 33.20 | +4715.34% |
| ALNY | Alnylam Pharmaceuticals Inc | 36.96 | +5260.70% |
| SNDX | Syndax Pharmaceuticals Inc | 37.64 | +5359.32% |
| OTLK | Outlook Therapeutics Inc | 38.42 | +5472.45% |
| HALO | Halozyme Therapeutics Inc | 38.61 | +5500.01% |
| ANL | Adlai Nortye Ltd | 38.65 | +5506.19% |
| DARE | Dare Bioscience Inc | 39.19 | +5584.14% |
| QNTM | FSD Pharma Inc - Class B - Class B (Sub Voting) | 42.25 | +6027.96% |
| TVTX | Travere Therapeutics Inc | 44.03 | +6286.13% |
| EXOZ | Invizyne Technologies Inc | 46.03 | +6576.21% |
| RYTM | Rhythm Pharmaceuticals Inc | 49.01 | +7008.43% |
| KALV | KalVista Pharmaceuticals Inc | 49.03 | +7011.33% |
| CYTK | Cytokinetics Inc | 60.31 | +8647.39% |
| GLSI | Greenwich LifeSciences Inc | 61.61 | +8835.94% |
| NBTX | Nanobiotix | 65.02 | +9330.53% |
| YDES | YD Bio Ltd | 66.53 | +9549.54% |
| PGEN | Precigen Inc | 68.45 | +9828.02% |
| OCGN | Ocugen Inc | 69.69 | +10007.87% |
| CELC | Celcuity Inc | 84.24 | +12118.21% |
| PROK | ProKidney Corp - Class A | 100.75 | +14512.55% |
| CNSP | Cns Pharmaceuticals Inc | 106.55 | +15354.06% |
| ANAB | AnaptysBio Inc | 117.87 | +16995.92% |
| EDIT | Editas Medicine Inc | 123.59 | +17825.55% |
| BBIO | BridgeBio Pharma Inc | 123.68 | +17838.61% |
| ELTX | Elicio Therapeutics Inc | 132.74 | +19152.67% |
| MNKD | Mannkind Corp | 187.85 | +27145.85% |
| GALT | Galectin Therapeutics Inc | 207.70 | +30024.91% |
| INBX | Inhibrx Biosciences Inc | 212.28 | +30689.19% |
| INDP | Indaptus Therapeutics Inc | 216.89 | +31357.83% |
| AGEN | Agenus Inc | 218.61 | +31607.30% |
| JUNS | Jupiter Neurosciences Inc | 227.66 | +32919.91% |
| MGTX | MeiraGTx Holdings plc | 228.30 | +33012.74% |
| AXSM | Axsome Therapeutics Inc | 231.57 | +33487.02% |
| RARE | Ultragenyx Pharmaceutical Inc | 247.70 | +35826.52% |
| VRNA | Verona Pharma Plc | 279.39 | +40423.23% |
| PLUR | Pluri Inc | 306.56 | +44363.61% |
| ONCY | Oncolytics Biotech Inc | 1055.04 | +152923.50% |
| PTCT | PTC Therapeutics Inc | 1743.27 | +252744.70% |
| FHTX | Foghorn Therapeutics Inc | 2005.35 | +290756.91% |